What you should know about the new Alzheimer’s drug

An older man rests his chin on his cane while sitting down at a table

In a highly anticipated announcement, the US Food and Drug Administration last week approved the first new drug for Alzheimer’s disease in nearly two decades.

That approval was not without controversy. Both before and after the FDA’s decision, physicians and researchers expressed a wide variety of perspectives on the drug’s potential, given a limited evidence base, and multiple stops and starts in its development and approval process.

The Alzheimer’s drug, called aducanumab during development and clinical trials, will be branded and sold as Aduhelm.

“I really believe this kicks off a new era in the fight against Alzheimer’s disease,” says Stephen Salloway, professor of neurology and psychiatry at Brown University who has been closely involved with the drug’s clinical development since the beginning.

Salloway directs the Memory and Aging Program at Butler Hospital and has been researching Alzheimer’s disease for 30 years.


 Get The Latest By Email

Weekly Magazine Daily Inspiration

He was a site principal investigator at Butler for both Phase 1 and Phase 3 trials of aducanumab, co-chair of the investigative steering committee for the Phase 3 program, and has advised the drug’s manufacturer, Biogen, on safety protocols and side effect management.

Here, he explains the key takeaways from the FDA’s headline-making decision and what it means for Alzheimer’s patients and for future research of the disease:

About The Author

Corrie Pikul-Brown

books_health

This article originally appeared on Futurity

AVAILABLE LANGUAGES

English Afrikaans Arabic Chinese (Simplified) Chinese (Traditional) Danish Dutch Filipino Finnish French German Greek Hebrew Hindi Hungarian Indonesian Italian Japanese Korean Malay Norwegian Persian Polish Portuguese Romanian Russian Spanish Swahili Swedish Thai Turkish Ukrainian Urdu Vietnamese

follow InnerSelf on

facebook icontwitter iconyoutube iconinstagram iconpintrest iconrss icon

 Get The Latest By Email

Weekly Magazine Daily Inspiration

Tuesday, 18 May 2021 16:15

In my blog posts, free resources, and courses, I talk a lot about the things that we can do to support and develop our inborn, natural interspecies communication abilities. In this post, I...

Monday, 17 May 2021 08:55

Maybe you’re trying to eat healthier these days, aiming to get enough of the good stuff and limit the less-good stuff. You’re paying attention to things like fiber and fat and vitamins… and...

Thursday, 01 April 2021 16:24

  Flamenco dancing is a delight to watch. A good flamenco dancer exudes an exuberant self-confidence that we, the audience, absorb. The whole dance has a quality of proud self-assurance and...

Monday, 24 July 2023 16:37

Uterine fibroids, or leiomyomas, are benign tumors commonly occurring in the uterus. They affect many women, particularly African Americans, and can lead to clinical symptoms such as abnormal...

Saturday, 01 May 2021 08:12

High-intensity interval training (HIIT) workouts have become popular in recent years for a number of reasons. They don’t require as much time as a regular workout (some can take as little as 10...

Sunday, 16 May 2021 14:24

The human body is an amazing thing, full of systems, organs, nerves, and vessels that work together in harmony. You’ve seen the body described as a machine, as a city, or even as a factory....

New Attitudes - New Possibilities

InnerSelf.comClimateImpactNews.com | InnerPower.net
MightyNatural.com | WholisticPolitics.com | InnerSelf Market
Copyright ©1985 - 2021 InnerSelf Publications. All Rights Reserved.